Drug Delivery Systems Market Growth, Analysis and Report Forecasts 2027 | Novartis AG, GlaxoSmithKline, Bausch Health Companies

The global drug delivery systems market by product segments was led by oral drug delivery segment. In 2018, the oral drug delivery segment held a largest market share of 50.2% of the drug delivery systems market, by route of administration. The transmucosal segment is expected to be the fastest growing segments the market in 2027 owing to rapidly rising incidence of chronic disorders, including gastrointestinal, respiratory, and autoimmune disorders.

The global drug delivery systems market accounted to US$ 1,243.1 Bn in 2018 and is expected to grow at a CAGR of 7.2% during the forecast period 2019 – 2027, to account to US$ 2,302.2 Bn by 2027.

Get sample PDF copy @ https://www.theinsightpartners.com/sample/TIPHE100000854/?openpr-10144

Emerging Players in the Drug Delivery Systems Market Research include:

BD
Novo Nordisk A/S
3M
Boston Scientific Corporation
Bausch Health Companies Inc.
Baxter International, Inc.,
Boehringer Ingelheim
Novartis AG
GlaxoSmithKline plc.
Johnson & Johnson Services

Asia Pacific is the fastest growing geographic market and it is expected to be the second largest revenue contributor throughout the forecast period. The growth is contributed majorly by driving factors such as significant rise in the prevalence of chronic diseases across the countries, rise in the government support for the patient population. In addition, the market players are also developing novel products in the countries through robust R&D activities and partnerships and acquisitions.

With the improvements in medical devices and certain transdermal delivery technologies, the non-invasive mode of drug delivery is now ready to compete with traditional methods of oral and injectible routes of drug delivery. The Non-Invasive Drug Delivery Systems encompasses the broad field of non-invasive drug delivery systems which includes drug delivery via topical, transdermal-active (device- aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, as well as delivery via alveolar membrane from inhaled medication. Patient compliance has been found to be much higher when administrated by non-invasive routes due to decreased pain involved in drug delivery and therefore these techniques are considered to be a preferred mode of drug delivery.

The report segments the global drug delivery systems market as follows:

Global Drug Delivery Systems Market – By Application
Hospital & Clinics
Home Care Settings
Others

Global Drug Delivery Systems Market – By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Drug Delivery Systems Market – By Route of Administration

Oral
Transmucosal
Injectable
Topical
Implantable
Ocular

Purchase this Report @ https://www.theinsightpartners.com/BUY/TIPHE100000854/?openpr-10144

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Semiconductors, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.